We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$484B
AUM Growth
+$13.2B
Cap. Flow
-$3.88B
Cap. Flow %
-0.8%
Top 10 Hldgs %
13.39%
Holding
2,630
New
93
Increased
1,078
Reduced
887
Closed
93

Sector Composition

Rank Sector Weight
1 Healthcare 21.05%
2 Consumer Discretionary 13.82%
3 Financials 13.14%
4 Industrials 11.9%
5 Technology 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJI
1776
DELISTED
South Jersey Industries, Inc.
SJI
$842K ﹤0.01%
31,040
AL
1777
DELISTED
Air Lease Corp
AL
$839K ﹤0.01%
22,229
BYD icon
1778
Boyd Gaming
BYD
$6.05B
$834K ﹤0.01%
58,700
-3,800
-6% -$52.3K
ITGR icon
1779
Integer Holdings
ITGR
$4.25B
$830K ﹤0.01%
15,742
-1,975
-11% -$93.7K
OPWR
1780
DELISTED
OPOWER INC COM STK (DE)
OPWR
$829K ﹤0.01%
81,800
-1,031,957
-93% -$12.6M
ISBC
1781
DELISTED
Investors Bancorp, Inc.
ISBC
$822K ﹤0.01%
70,126
+7,200
+11% +$81.7K
VR
1782
DELISTED
Validus Hold Ltd
VR
$821K ﹤0.01%
19,500
MDP
1783
DELISTED
Meredith Corporation
MDP
$820K ﹤0.01%
14,700
+3,200
+28% +$172K
CHL
1784
DELISTED
China Mobile Limited
CHL
$820K ﹤0.01%
12,616
-147
-1% -$9.59K
TIME
1785
DELISTED
Time Inc.
TIME
$815K ﹤0.01%
36,330
+5,278
+17% +$126K
FMER
1786
DELISTED
FIRSTMERIT CORP
FMER
$808K ﹤0.01%
42,376
LGF
1787
DELISTED
Lions Gate Entertainment
LGF
$807K ﹤0.01%
23,800
+5,300
+29% +$166K
FWRD icon
1788
Forward Air
FWRD
$682M
$806K ﹤0.01%
14,835
-2,400
-14% -$123K
EFII
1789
DELISTED
Electronics for Imaging
EFII
$806K ﹤0.01%
19,300
-415
-2% -$16.5K
WSO icon
1790
Watsco Inc
WSO
$12.9B
$804K ﹤0.01%
6,400
INFN
1791
DELISTED
Infinera Corporation Common Stock
INFN
$803K ﹤0.01%
40,800
+4,000
+11% +$67.2K
BDN
1792
Brandywine Realty Trust
BDN
$542M
$800K ﹤0.01%
50,043
+2,000
+4% +$32.2K
MDR
1793
DELISTED
McDermott International
MDR
$794K ﹤0.01%
68,883
+39,100
+131% +$335K
HLSS
1794
DELISTED
HOME LN SERVICING SOLUTIONS LTD(CAYMAN ISLANDS)
HLSS
$794K ﹤0.01%
48,000
+17,500
+57% +$288K
RIGL icon
1795
Rigel Pharmaceuticals
RIGL
$762M
$793K ﹤0.01%
22,220
+500
+2% +$13.7K
SUI icon
1796
Sun Communities
SUI
$14.6B
$791K ﹤0.01%
11,850
+1,300
+12% +$87.3K
EQC
1797
DELISTED
Equity Commonwealth
EQC
$787K ﹤0.01%
29,650
TIVO
1798
DELISTED
Tivo Inc
TIVO
$787K ﹤0.01%
43,233
+4,900
+13% +$110K
CRUS icon
1799
Cirrus Logic
CRUS
$6.08B
$786K ﹤0.01%
23,640
+2,600
+12% +$75.5K
SGMO
1800
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$786K ﹤0.01%
50,100
+3,100
+7% +$48K

Similar funds

T. Rowe Price Associates's Q1 2015 Portfolio in Review

As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
  • T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
  • T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
  • T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
  • T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.